Cancer Vaccines Market Analysis 2022-2027: Global Trends, Share, Size, Growth and Forecast

The latest research study "Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the Global Cancer Vaccines Market size reached US$ 5.43 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.72 Billion by 2027 exhibiting a CAGR of 11.70% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/cancer-vaccines-market/requestsample

Industry Definition and Application:

Cancer vaccines, alternatively referred to as immunotherapy, represent medicines that help the immune system of the body to identify and destroy cancer cells. They can be broadly categorized into preventive and therapeutic vaccines. These cancer vaccines aid in eliminating cancer caused by oncovirus, offering protection from human papilloma virus (HPV), and stimulating the adaptive immune systems by using tumor antigens. They have the advantages of low toxicity, exquisite specificity, and potential for durable treatment effect. Consequently, cancer vaccines are in high demand among consumers across the globe.

Cancer Vaccines Market Trends and Drivers:

The elevating prevalence of cancer, owing to the rising consumption of tobacco-based products and unhealthy lifestyles, is primarily driving the cancer vaccines market. Besides this, the launch of several policies by the government bodies aimed at promoting novel vaccine technologies for cancer and the introduction of viral recombinant vaccine treatments are acting as significant growth-inducing factors.

Moreover, the growing geriatric population and the expanding human papilloma virus (HPV) infections are positively influencing the global market.

Additionally, the inflating investments in research and development activities (R&D) by leading market players to gain a competitive edge and the escalating advancement of healthcare infrastructure, especially in developing countries, are expected to stimulate the cancer vaccines market in the coming years.

Click here to view detailed information with table of content: https://www.imarcgroup.com/cancer-vaccines-market

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:
• Preventive Cancer Vaccines
• Therapeutic Cancer Vaccines

Breakup by Technology:
• Dendritic Cells Cancer Vaccines
• Recombinant Cancer Vaccines
• Antigen/Adjuvant Cancer Vaccines
• Viral Vector and DNA Cancer Vaccines
• Whole-cell Cancer Vaccines

Breakup by Indication:
• Cervical Cancer
• Prostate Cancer
• Others

By Geography:
• North America
o United States
o Canada

• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others

• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others

• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

List of Major Key Players:
The major players in the market are Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.

Also, Read Latest Research Reports by IMARC Group:

Commercial Drones Market: https://www.imarcgroup.com/commercial-drones-market

Managed Application Services Market Trends: https://www.imarcgroup.com/managed-application-services-market

Purified Terephthalic Acid (PTA) Market Report: https://www.imarcgroup.com/purified-terephthalic-acid-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.